2022 HEDIS® Measures
Statin Therapy for Patients with Cardiovascular Disease • Men dispensed a high or moderate21-75 • Women 40-75 Percent of members who were identified as having clinical atherosclerotic cardiovascular disease (ASCVD) who were -intensity statin medication. Two rates are reported: • Received statin therapy; dispensed at least one
Download 2022 HEDIS® Measures
Information
Domain:
Source:
Link to this page:
Documents from same domain
Medical Record Completion Guidelines - McLaren …
www.mclaren.org1 Medical Record Completion Guidelines Medical Record Committee Approval: August 24, 2011 Staff Executive Committee Approval: September 2011
Authorization to Release Information - mclaren.org
www.mclaren.orgAuthorization to Release Information Revised 06/2015 Form Number to be issued by Vendor Patient Name Birthdate Medical Record Number
EMPLOYEE OF THE MONTH - mclaren.org
www.mclaren.orgEMPLOYEE OF THE MONTH When it comes to Doing What’s Best Tammy makes things as easy as possible for the patients. Tammy Jackson has been with McLaren Bay Region for nine years. Her role as a nursing clerk at Karmanos entails scheduling, assisting patients in getting
Good Clinical Practice - mclaren.org
www.mclaren.orgguidelines and that clinical trials are conducted in accordance with the ethical principles that have their origin in ... Good Clinical Practices (GCP), Applicability to Human Subjects Research Page 3 of 4 2. The Investigator informs a subject when medical care is needed for other illnesses of which the Investigator becomes aware. (ICH-GCP 4.3.2)
Financial Assistance Application Instructions
www.mclaren.orgAll requested information must be returned in order to be processed/reviewed for Financial Assistance. If you have any questions or need any assistance with completing the application please contact: OR FinancialAssistance@mclaren.org Patient Financial Services Customer Services Department 321-1557 MHCC 542A- 52 (1 )/
Related documents
Table 5. Statin Dose Intensity and Equivalency Chart* - MQIC
www.mqic.orgStatin Intensity %LDL-C Reduction HMG-CoA Reductase Inhibitor Rosuvastatin Atorvastatin Pitavastatin Simvastatin Lovastatin Pravastatin Fluvastatin High-Intensity (lowers LDL-C ≥ 50%) 63 40 mg ($196) 62 61 60 80mg ($9 gen, $ 236. br) 59 58 56 20 mg 54 ($196) 52 10 mg ($196) 50 40mg ($9 gen, $ 236. br) Moderate-
Simplified lipid guidelines - Canadian Family Physician
www.cfp.castatins, statin therapy should be maximized first(to high intensity) (high-level evidence). Follow-up • The use of cholesterol targets for reducing CVD is not required (high-level evidence). • We suggest that the monitoring of repeat lipid levels after a patient begins lipid-lowering therapy is not required (low-level evidence).
Summary of National Guidance for Lipid Management for ...
www.england.nhs.uklow- or medium-intensity statin the likely benefits and potential risk of side effects if changed to a high-intensity statin when they have a medication review and agree with the person whether a change is needed. Ezetimibe, alirocumab, evolocumab or inclisiran can be added when patients’
WHEN AND HOW TO PRESCRIBE STATINS
www.ksw-gtg.comThe appropriate intensity of statin therapy should be initiated or continued: 1. Clinical ASCVD a. Age ≤75 y and no safety concerns: High-intensity statin I A b. Age >75 y or safety concerns: Moderate-intensity statin I A 2. Primary prevention—Primary LDL-C ≥190 mg/dL a.
Guidance for the management of hypertriglyceridaemia
www.ncl-mon.nhs.ukStatin Guidance, Appendix 1). Review in 2-3 months Low CVD risk High risk or established CVD of pancreatitis lifestyle, review in 3-6 months Offer ... Physical activity (at least 150 minutes of moderate intensity aerobic activity or 75 minutes of vigorous intensity aerobic activity)
CORCAL RESEARCH STUDY - Intermountain Healthcare
intermountainhealthcare.orgmoderate-intensity statin therapy. · A greater than 20 percent risk is considered high. It is recommended that you start with high-intensity statin therapy. What should I do now? Talk with your primary care provider to discuss the treatment option that is …